Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Keratosis, Actinic × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 18 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Ganglioneuroblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Penile Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1

Interventions

Aminolevulinic Acid 11 3-ingenyl angelate 9 Photochemotherapy 5 Imiquimod 5 Fluorouracil 4 Petrolatum 3 Solutions 2 SR-T100 2 Gels 2 Cryotherapy 2 potassium dobesilate 1 perillyl alcohol 1 endonuclease V, phage T4 1 dehydroftorafur 1 calcipotriene 1 afamelanotide 1 Triamcinolone 1 Therapies, Investigational 1 Papillomavirus Vaccines 1 Ointments 1 Melatonin 1 LEO 43204 1 Isotretinoin 1 Imipramine 1 Excipients 1 Eflornithine 1 Deoxyribonuclease (Pyrimidine Dimer) 1 Cholecalciferol 1 Chemexfoliation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278861 2014-10-30

ARISOAK

Universidade Federal de Goias

Phase 2 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡